Spirit of Community Luncheon

  • Dec 15, 2020
  • 1:00 PM - 2:00 PM

Join Cancer Support Community LA for a panel with some of Los Angeles’ top experts in oncology and psycho oncology from Cedars Sinai, UCLA Health and Providence Saint John’s Health Center as they sit down with CSCLA CEO, Julia Forth, for an in depth discussion.

Prevention is Better Than a Cure

  • Oct 15, 2020

Nadia Bilchik from Nadia Speaks, interviewed Dr. Jennifer Linehan, associate professor of urology and urologic oncology, and Dr. Anton Bilchik, professor of surgical oncology, about how to prevent some of the most common things that people suffer from. Watch the interview to learn how to make simple lifestyle choices to improve your health and wellbeing.

Frankly Speaking About Cancer: Making Treatment Decisions

  • Jul 31, 2020
  • 1:00 PM - 2:00 PM

After a cancer diagnosis, people with cancer & their families have to make a number of decisions about their treatment options. However, most people don’t know where to start. Decisions about cancer treatment are personal, and you need to feel comfortable with your choices. Learn how to navigate the decision-making process from Ana Rocha, NP and Joseph Greenberg, LCSW of Providence Saint John’s Health Center, by watching their webinar.

COVID-19 Breakthroughs: Dexamethasone, ECMO, and COVID-19 Clinical Trials

  • Jun 29, 2020
  • 12:00 PM

Dr. Steven J. O’Day, M.D., Executive Director of the Saint John’s Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, explains new advancements with Dexamethasone, ECMO treatment, and how our researches are adapting to find a vaccine for COVID-19.

Promising News in the Fight Against Coronavirus

  • Jun 16, 2020
  • 4:00 pm

Dr. Steven O’Day, M.D., was interviewed by the Los Angeles Times, CBS/KCAL and NBC, on a new British study that touts steroids as a breakthrough treatment for serious cases of COVID-19. Listen to Dr. O’Day discuss this new promising study.

Promising Steroid Treatment for Serious Cases of COVID-19

  • Jun 16, 2020
  • 3:00 pm

Promising Steroid Treatment for Serious Cases of COVID-19 CBSN Los Angeles interviewed Dr. Steven O’Day, M.D., Executive Director of the Saint…

Agenus NextGen CTLA-4 Antibody Data Presented at ASCO

  • May 31, 2020
  • 8:00 AM

Dr. Steven J. O’Day, M.D., presented Agenus NextGen CTLA-4 Antibody (AGEN1181) Data at the American Society of Clinical Oncology (ASCO) Virtual Scientific Program. Watch his poster presentation to learn about the data and how it’s benefiting a broad population of cancer patients.

Providence Saint John’s Medical Center in Santa Monica Participating in COVID-19 Clinical Trials

  • May 19, 2020
  • 11:00 AM

Dr. Steven O’Day, M.D., joined host Alex Cohen from Inside the Issue, Spectrum News 1, to discuss the cutting-edge COVID-19 clinical trials at the Saint John’s Cancer Institute Saint John’s Health Center.

Activating Innate Immunity in Triple-Negative Breast Cancer and Other Tumors

  • May 11, 2020
  • 1:00 PM

Watch Steven J. O’Day, M.D., Executive Director of the Saint John’s Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, discusses the rationale for using Imprime PGG to trigger immunity and possibly enhance response to pembrolizumab in patients with metastatic triple-negative breast cancer.

Triple-Negative Breast Cancer: Clinical Benefit With Pembrolizumab Plus Imprime PGG

  • May 8, 2020
  • 1:00 PM

Steven J. O’Day, M.D., Executive Director of the Saint John’s Cancer Institute and Cancer Clinic, and Director of Providence Los Angeles Regional Research, presented: Triple-Negative Breast Cancer: Clinical Benefit With Pembrolizumab Plus Imprime PGG at the AACR Annual Meeting. Watch his virtual presentation to learn the results.